After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Bi-partisan legislation was introduced in the U.S. House of Representatives to get primary care physicians more training on ...

A surprising discovery about how brain cells handle sugar could shift how scientists approach dementia and Alzheimer’s ...

Updated label allows Neuraceq to be used in selecting patients for amyloid-targeting therapies and includes the use of ...

Researchers at McMaster University, Cleveland Clinic and Case Comprehensive Cancer Center have uncovered how a protein long ...

Eli Lilly and Company (NYSE: LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

Breast cancer treatment might offer protection against Alzheimer's disease, with a study of 70,000 survivors showing lower ...

What exactly is Alzheimer’s disease, and how common is it? A: Alzheimer’s disease is a neurodegenerative disease that causes dementia. It is caused in part by the accumulation of abnormally folded ...

Scientists identify stress granules as the potential root cause of Alzheimer's disease. This new understanding may ...

Cognito Therapeutics has reached its enrolment goal for the HOPE Study investigating the Spectris AD system for Alzheimer's disease (AD).